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structing the bronchial anastomosis, whereas others prefer
the “increased security” of the telescoped anastomosis.3-5
Reported rates of bronchial anastomotic complications
for these two techniques vary widely between transplant
centers.4-13 Other than technical factors, variables that
may influence anastomotic healing are preoperative corti-
costeroid therapy, presence of purulent airway secretions
such as in patients with cystic fibrosis, single lung versus
bilateral lung transplants, use of cardiopulmonary bypass,
postoperative infusion of prostaglandin, degree of reper-
fusion injury, postoperative cytolytic therapy, and postop-
erative acute rejection.6-9 Previous study populations have
represented a combination of these diverse influences. 
To minimize the effect of many of these variables on
bronchial anastomotic healing, we selected a relatively
Impaired healing of the bronchial anastomosis threatenssuccessful outcome after lung transplantation.1,2 Some
centers prefer the traditional end-to-end technique in con-
Objective: To assess the influence of surgical technique (telescoped versus
end-to-end anastomosis) on the incidence of bronchial anastomotic compli-
cations in patients who underwent single lung transplantation for pulmonary
emphysema. 
Methods: Seventy-six adult recipients of single lung transplants for pul-
monary emphysema were evaluated for the presence of 3 types of major
bronchial anastomotic complications: ischemia, dehiscence, and severe
stenosis. Surgical technique, clinical course, and mortality were reviewed
retrospectively. 
Results: The 3 major complications were observed in 11 (34%; ischemia), 8
(25%; dehiscence), and 11 (34%; severe stenosis) of 32 telescoped bronchial
anastomoses. In contrast, ischemia, dehiscence, and severe stenosis occurred
in only 4 (9%), 1 (2%), and 2 (5%) of 44 end-to-end anastomoses (P = .0087,
P = .0034, and P = .0012, respectively). The relative risk of ischemia, dehis-
cence, and severe stenosis in telescoped anastomoses was 2.1, 2.5, and 2.5,
respectively, compared with end-to-end anastomoses. Five (13%) telescoped
anastomoses required stent placement as compared with only 2 (5%) end-to-
end anastomoses (P = .1244). Early postoperative pneumonia was more
common in the telescoped anastomosis group (56%) than in the end-to-end
group (32%; P = .0380). There was a trend toward shorter survival in the
telescoped anastomosis group (mean survival 1045 ± 145 days) as compared
with the end-to-end group (mean survival 1289 ± 156 days), but these dif-
ferences did not achieve statistical significance (P = .2410). 
Conclusions: In patients who underwent single lung transplantation for pul-
monary emphysema, telescoped anastomoses were associated with a higher
incidence of bronchial anastomotic complications than end-to-end anasto-
moses. (J Thorac Cardiovasc Surg 2001;121:149-54)
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homogeneous group of patients with pulmonary
emphysema who underwent single lung transplanta-
tion at our institution. The purpose of the study was to
assess the influence of surgical technique on the inci-
dence of bronchial anastomotic complications in this
selected population. 
Methods
Study population. Eighty-two adult patients underwent
single lung transplantation for advanced pulmonary
emphysema at our institution between 1990 and 1999. Six
(7.3%) transplant recipients died within 30 days after the
operation of causes unrelated to bronchial anastomotic
healing and were excluded from analysis. The records of
the remaining 76 patients were analyzed retrospectively. A
bronchoscopic description in 23 patients has been previ-
ously reported.14
Operative technique. Two types of surgical technique
were used for construction of bronchial anastomoses. The
first (n = 44 patients) was a simple end-to-end anastomosis
carried out with running polydioxanone 4-0 suture (PDS;
Ethicon, Inc, Somerville, NJ) on the posterior membranous
portion of the bronchus followed by interrupted sutures to
reapproximate the cartilaginous portion of the bronchus.
Neither pericardial nor omental wrapping was routinely
used. The second technique (n = 32 patients) was a tele-
scoped anastomosis.3 In this technique, the donor bronchus
was invaginated into the recipient bronchus by 1 to 2 carti-
laginous rings and then sewn with running sutures posteri-
orly and interrupted sutures anteriorly. Choice of anasto-
motic technique was determined by individual surgeon
preference. The end-to-end anastomosis was used continu-
ously over the course of the 10-year review. The telescoped
anastomosis became more popular in our institution after
1994 because of initial favorable reports in the literature.
No bronchial revascularization procedures were used.
Cardiopulmonary bypass was not required except briefly
(20 minutes) for 1 patient for transient hemodynamic insta-
bility. 
Therapeutic regimen. Standard immune suppression con-
sisted of prednisone, cyclosporine (INN: ciclosporin), and
azathioprine. After 1996, mycophenolate was substituted for
azathioprine. Prednisone 1 mg/kg per day was begun imme-
diately after the operation and tapered to 0.1 to 0.15 mg/kg
per day by 3 months after the operation. Episodes of rejection
were treated with intravenous infusion of methylprednisolone
(1 g per day) for 3 days. No patients received perioperative
cytolytic therapy. All patients received perioperative antibi-
otics consisting of vancomycin and aztreonam or gentamicin
for 72 hours after the operation. Subsequent antibiotics were
adjusted on the basis of operative cultures and clinical course.
Prophylaxis against Pneumocystis carinii pneumonia was
administered to all patients. Antiviral prophylaxis was modi-
fied according to the cytomegalovirus (CMV) serologic status
of the donor and recipient.15
Clinical follow-up. After the operation, patients underwent
intensive postoperative surveillance in the hospital, followed
by regular, frequent visits in the outpatient department.
Complete physical examinations, pulmonary function testing,
chest radiography, and blood tests were performed weekly for
the first 2 months, biweekly for the next 2 months, and then
at monthly intervals thereafter indefinitely. Mean follow-up
time for all patients was 2.9 ± 2.4 years (range 0.1-8.8 years).
No patient was lost to follow-up. 
Bronchoscopic examination. Patients were routinely
examined with a fiberoptic bronchoscope in the immediate
postoperative period to assess bronchial anastomotic sites and
lower airways, as well as to suction respiratory secretions for
culture. Bronchoscopic examination was repeated whenever
clinically necessary for reinspection of bronchial anasto-
moses, suctioning of secretions, or clinical-radiographic signs
of infection or rejection.15 In the absence of symptoms or
abnormalities on the chest radiograph, surveillance broncho-
scopic examination including transbronchial biopsy was per-
formed 3 weeks postoperatively and then every 3 months dur-
ing the first postoperative year. During the second
postoperative year, surveillance bronchoscopy was performed
every 4 months and thereafter every 6 months.
Bronchoalveolar lavage and transbronchial biopsies were per-
formed according to standard techniques.15
Diagnostic criteria. For purposes of this study, anastomotic
ischemia was defined as black, necrotic exudate covering more
than 50% of the anastomotic circumference as viewed through
the bronchoscope. Anastomotic dehiscence was defined as dis-
ruption of more than 25% of the circumferential suture line as
observed through the bronchoscope. Severe stenosis was
defined as narrowing of the bronchial lumen to less than 4.9
mm in diameter (the outer diameter of the bronchoscope). 
Comparison between bronchial anastomotic groups.
Variables applied in statistical analysis were grouped in 5
broad categories:
1. Preoperative donor variables: donor age, sex, race,
smoking, Gram stain, HLA type, CMV status 
2. Preoperative recipient variables: recipient age, sex, race,
preoperative corticosteroids, HLA type, CMV status 
3. Preoperative donor-recipient matching: age, sex, race,
HLA type, CMV status 
4. Intraoperative variables: ischemic time, right lung versus
left lung transplant, cardiopulmonary bypass, surgeon 
5. Postoperative complications: ischemia-reperfusion 
injury, postoperative pneumonia, diaphragmatic paraly-
sis, CMV pneumonitis 
Ischemia-reperfusion was assessed by hypoxemia
(arterial oxygen tension/inspired oxygen fraction) and lung
injury scores.16 The diagnosis of postoperative pneumonia
was based on the presence of a new intrathoracic opacity
(other than atelectasis) within 30 days after transplantation
and (1) culture, serologic, cytologic, or histopathologic evi-
dence of a specific organism or organisms or (2) a clinical
course in which pulmonary infection appeared highly likely
in association with response to antimicrobial therapy.15
Statistical methods. Survival statistics were calculated by
the method of Kaplan and Meier. Observed proportions were
compared by means of the Fisher exact test. Calculated
means were compared by the Student t test. 




Comparison of preoperative variables between patients
receiving telescoped anastomoses versus end-to-end anas-
tomoses. No significant preoperative differences were
observed between the group receiving telescoped anas-
tomoses versus end-to-end anastomoses in any mea-
sured variable (Table I). In the telescoped group (n = 32
patients), mean age at the time of the operation was 56
± 8 years (range 41-67 years). Twenty (63%) transplant
recipients were women and 12 (37%) were men.
Fifteen patients received a right single lung transplant
(47%), and 17 received a left single lung transplant
(53%). Twenty (63%) patients were receiving long-
term corticosteroid therapy at the time of the operation.
In the end-to-end group (n = 44 patients), mean age at
the time of the operation was 55 ± 7 years (range 41-64
years). Twenty-seven (61%) transplant recipients were
women, and 17 (39%) were men. Twenty-two patients
received a right single lung transplant (50%), and 22
received a left single lung transplant (50%). Twenty-six
(59%) were receiving long-term corticosteroid therapy. 
Bronchial anastomotic complications. The 3 major
complications, ischemia, dehiscence, and severe steno-
sis, were observed in 11 (34%), 8 (25%), and 11 (34%),
respectively, of 32 telescoped bronchial anastomoses
(Table II; Figs 1 and 2). In contrast, ischemia, dehis-
cence, and severe stenosis occurred in only 4 (9%), 1
(2%), and 2 (5%) of 44 end-to-end anastomoses,
respectively. These differences were statistically signif-
icant for the occurrence of all 3 anastomotic complica-
tions (see Table II). The relative risk of ischemia, dehis-
cence, and severe stenosis in telescoped anastomoses
was 2.1, 2.5, and 2.5, respectively, compared with end-
to-end anastomoses. Five (13%) telescoped anasto-
moses required stent placement as compared with only
2 (5%) end-to-end anastomoses (P = .1244). 
Comparison of postoperative variables between
patients receiving telescoped anastomoses versus end-
to-end anastomoses. No significant postoperative differ-
ences existed between the bronchial anastomotic groups
with regard to ischemic time or other immediate postop-
erative variables such as hypoxemia score, lung injury
score, median ventilator days, and median stay in the
intensive care unit (Table III). The only difference
between the two groups was a higher incidence of post-
operative pneumonia in the telescoped anastomosis
group (56%) as compared with the end-to-end group
(32%) (P = .0380). Later events such as CMV pneumo-
nia, time to acute rejection, severity or frequency of acute
rejection episodes, and time to chronic rejection were not
significantly different between the two groups (Table III). 
There was no relation between the side of bronchial
anastomosis (right vs left) and the incidence of anasto-
motic complications. Similarly, there was no relation
between doses of preoperative or postoperative cortico-
steroids and the incidence of anastomotic complications. 
Effect of anastomotic complications on survival.
Survival tended to be shorter in the telescoped anasto-
mosis group (mean survival 1046 ± 145 days) than in
the end-to-end group (mean survival 1289 ± 156 days),
but these differences did not achieve statistical signif-
icance (P = .2410; Table III). Two deaths were direct-
ly related to an anastomotic complication. Both
patients had locally invasive Aspergillus infection at
the site of a necrotic telescoped anastomosis, followed
in 1 patient by fatal disseminated Aspergillus infec-
tion. In the second patient, local erosion of the
bronchus into an adjacent pulmonary artery caused
massive fatal hemoptysis. 
Discussion
The results of the present study demonstrate a high
incidence of anastomotic complications associated
with the telescoping technique in patients who under-
went single lung transplantation for pulmonary emphy-
sema. The incidence of bronchial anastomotic compli-
cations in the telescoped group (ischemia 34%,
dehiscence 25%, severe stenosis 34%) was significant-
ly higher than the incidence of anastomotic complica-
tions in the end-to-end group (ischemia 9%, dehiscence
2%, severe stenosis 5%). Other than anastomotic tech-
nique, no differences could be identified between the
two groups to account for the different rates of
bronchial anastomotic complications. 
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Table I. Comparison of preoperative variables between patients receiving telescoped anastomoses versus end-to-
end anastomoses
Variable T anastomoses (n = 32 patients) EE anastomoses (n = 44 patients) P value: T vs EE
Mean age (y) 56 ± 8 55 ± 7 NS
Female 20 (63%) 27 (61%) NS
Right lung transplant 15 (47%) 22 (50%) NS
Long-term corticosteroid therapy 20 (63%) 26 (59%) NS
T, Telescoped; EE, end-to-end; NS, not significant. 
The results of this study are not strictly comparable
with previously reported series.3-13 The earliest reports
in the transplant literature described end-to-end anasto-
moses, usually buttressed with a viable tissue pedicle
flap such as omentum.4-6 Subsequently, the “tele-
scoped” anastomosis was introduced to provide
increased security to the cartilaginous airway and to
obviate the need for routine omentopexy.3 After
Calhoon and associates3 reported no complications
with the telescoped anastomosis, several transplant
centers switched to this technique and observed fewer
anastomotic complications compared with the end-to-
end anastomosis.1-7 Other centers, however, observed
very high rates of stenosis associated with the tele-
scoped anastomosis8,9,13 and low rates of complications
with the end-to-end anastomosis.8,9,11,13 Some of the
improvement associated with switching from the end-
to-end anastomosis to the telescoped anastomosis may
have reflected increased surgical experience and
improved methods of suturing the telescoped anasto-
mosis.1,7 Centers that continued to use the end-to-end
technique attributed improved results to abandoning
the omental wrap8,11 or using pericardial or other tissue
wrap instead.9 The result of all of these studies is a
bewildering series of reports in the transplant literature
describing widely divergent bronchial anastomotic
complication rates ranging from 0% to 48% for tele-
scoped anastomoses3,59,11 and from 0% to 32% for end-
to-end anastomoses.4-8,10,11
Comparison of bronchial anastomotic complication
rates between transplant centers is restricted by 3 major
limitations. First, no system of classifying airway dam-
age after lung transplantation has been universally
accepted.2 Two classification systems have been pro-
posed, but neither has gained widespread acceptance.2,17
The system of Couraud and associates17 provides an
assessment of early anastomotic healing. The system of
Shennib and Massard2 was expanded to include late air-
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Fig 1. Telescoped right bronchial anastomosis in a 53-year-
old man 4 weeks after single lung transplantation for pul-
monary emphysema. There was persistent exudate and necro-
sis of the medial flange (arrow) of the telescoped
anastomosis. The patient had recurrent episodes of bacterial
pneumonia. 
Fig 2. Telescoped right bronchial anastomosis in a 55-year-
old woman 3 months after single lung transplantation for
emphysema. There was narrowing at the anastomotic site and
recurrent pooling of yellow-black secretions (arrow) in the
cul de sac formed by the redundant edge of donor bronchus
and recipient bronchus. Removal of the accumulated secre-
tions revealed clumps of Aspergillus hyphae.
Table II. Incidence of anastomotic complications in 76 patients after single lung transplantation for pulmonary
emphysema
T anastomoses EE anastomoses P value Relative risk: T vs EE
Complication (n = 32 patients) (n = 44 patients) (T vs EE) (95% CI)
Ischemia 11 (34%) 4 (9%) .0087 2.1 (1.3, 3.4)
Dehiscence 8 (25%) 1 (2%) .0034 2.5 (1.6, 3.7)
Stenosis 11 (34%) 2 (5%) .0012 2.5 (1.7, 3.9)
Stent 5 (13%) 2 (5%) .1244 1.8 (1.0, 3.2)
EE, End-to-end; T, telescoped; CI, confidence intervals. 
way complications as well. The system used in the pres-
ent study was far less complex than those described by
these 2 classification systems and included only the most
severe degrees of ischemia, dehiscence, and stenosis,
corresponding to Couraud grade 3 and Shennib grades
4b and 5b.2,17 The purpose of including only the most
severe degrees of ischemia, dehiscence, and stenosis in
the present study was to guarantee inclusion of only clin-
ically significant complications. 
Second, the rate of reported bronchial anastomotic
complications depends on how vigorously such com-
plications are sought and how uniformly such compli-
cations are defined. In the present series, we main-
tained a high level of vigilance in detecting
anastomotic complications by performing routine sur-
veillance bronchoscopic examination in the immediate
postoperative period and then 3 weeks after the opera-
tion. In addition, we adhered to uniform bronchoscop-
ic criteria to guarantee homogeneous recording of
observations and inclusion of only clinically significant
endoscopic findings. 
Third, bronchial anastomotic healing may be strong-
ly affected by heterogeneity of the transplant popula-
tion being studied, as well as by differences in preop-
erative and postoperative variables. Previously
published reports combined a mixture of patients with
cystic fibrosis and other lung diseases,7 single lung and
bilateral lung transplants,8 patients who did and did not
require cardiopulmonary bypass,8 and patients who did
and did not receive cytolytic therapy.4,8 Similarly, many
previously published reports did not assess the degree
of reperfusion lung injury, postoperative hypoxemia,
pneumonia, and acute rejection. 
We believe that a large component of the disparity of
bronchial anastomotic complication rates between
transplant centers relates to lack of uniform diagnostic
criteria, differences in the vigilance of evaluating air-
ways postoperatively, and heterogeneity of study popu-
lations. To minimize many of these variables, we
selected a relatively homogeneous group of patients
with pulmonary emphysema who underwent single
lung transplantation. Since this was a retrospective
review, however, some degree of heterogeneity still
persisted, such as use of preoperative corticosteroids
and right versus left lung transplant procedure.
Fortunately, data analysis revealed no identifiable pre-
operative or perioperative differences between the tele-
scoped and the end-to-end anastomosis groups to
account for the different rates of bronchial anastomotic
complications (Tables I and III). 
The only differences between the two groups of
bronchial anastomoses were a higher incidence of post-
operative pneumonia and a trend toward shorter sur-
vival time after lung transplantation in patients who
received telescoped anastomoses (Table III).
Anastomotic ischemia and dehiscence foster bacterial
and fungal overgrowth and restrict clearance of lower
respiratory tract secretions2 (Fig 1). In the telescoped
anastomosis, there is often an obstructing flange of car-
tilage or nonuniform invagination of the donor
bronchus into the wall of the recipient bronchus, which
also impairs clearance of secretions6 (Fig 2). Severe
stenosis further impairs clearance of lower airway
secretions.11 Presumably, a combination of these fac-
tors contributed to the higher incidence of postopera-
tive pneumonia and possibly to the trend to shorter sur-
vival after lung transplantation associated with the
telescoped anastomoses. It is possible that postopera-
tive pneumonia may have been the cause rather than the
consequence of poor anastomotic healing. However,
we do not believe that postoperative pneumonia was
more common in the telescoped group as a result of
The Journal of Thoracic and
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Table III. Comparison of postoperative variables between patients receiving telescoped anastomoses versus end-
to-end anastomoses
Variable T anastomoses (n = 32 patients) EE anastomoses (n = 44 patients) P value: T vs EE
Ischemic time (min) 210 ± 49 213 ± 50 NS
Day 1 hypoxemia score 255 ± 100 281 ± 115 NS
Lung injury score 0.9 ± 0.8 0.9 ± 0.7 NS
Median ventilator support (d) 2 2 NS
Median ICU stay (d) 5 5 NS
Median hospital stay (d) 31 29 NS
Postoperative pneumonia 18 (56%) 14 (32%) .038
CMV pneumonia 12 (38%) 15 (34%) NS
Mean time to acute rejection (d) 138 ± 27 156 ± 35 NS
Chronic rejection at 3 y (%) 38 26 NS
Mean survival (d) 1045 ± 145 1289 ± 156 .241
T, Telescoped; EE, end-to-end; NS, not significant; ICU, intensive care unit; CMV, cytomegalovirus. 
reperfusion lung injury, graft ischemic time, stay in the
intensive care unit, or duration of ventilatory assis-
tance, because these variables were comparable
between the two groups (Table III).
The data from the present study support the conclu-
sion that in our institution, telescoped anastomoses were
associated with a higher incidence of bronchial anasto-
motic complications than end-to-end anastomoses in
patients who underwent single lung transplantation for
pulmonary emphysema. Telescoped anastomoses also
had a deleterious effect on postoperative pneumonia and
possibly survival. We recommend that each transplant
center critically review its own bronchial anastomotic
data with these considerations in mind. 
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